Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. B. Migliori (Tradate, Italy). Other options of prevention - the current state and the future. Annual Congress 2003 - Latent tuberculosis infection - preventive approaches

Member's Comments

No comment yet.

Related content which might interest you: Halotherapy and Covid-19: an oppinion for a possible future prevention approach Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Therapeutic management - Current status and future developments Source: COVID-19 Videos Year: 2020 How to make interventions more successful in the future Source: International Congress 2015 – PG13 Monitoring physical activity Year: 2015 Current and future preventive and treatment strategies in CLAD Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation Year: 2015 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Pharmacological options for the treatment of COPD: present and future Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007 CF clinical care and its delivery: current and future challenges Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission Year: 2019 Anti-IgE therapy: current knowledge and future perspective Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Smoking reduction - update on efficacy, definitions and motivation strategies Source: Annual Congress 2003 - PG20 - Smoking reduction and smoking cessation - an update and suggestions for future studies Year: 2003 Rethinking the way we are treating established airway disease: current guidelines need to change  Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma Year: 2016 Challenges, impact and the future Source: Eur Respir Monogr 2019; 83: 240-244 Year: 2019 Biologics: current use and future applications for personalised therapy Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 The present and the future of vaccines and other preventive measures in the era of EID Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021 ACCP1 - Is telemedicine in your future? Source: Annual Congress 2008 - MP17 - ACCP: Is telemedicine in your future? Year: 2008 Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 Laboratory investigations of infection in COPD: current best practice and future possibilities Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008